21 Reasons That May Make RSA Insurance Group plc A Buy

Royston Wild reveals why shares in RSA Insurance Group plc (LON: RSA) look set to march higher.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am explaining why I believe RSA Insurance Group (LSE: RSA) (NASDAQOTH: RSANY.US) is a great growth stock at a stunning price.

Earnings explosion looks on the cards

In my opinion RSA Insurance’s surging progress across all of its major markets, aided by shrewd M&A activity in recent years across Latin America and Canada, makes it a great candidate for stunning earnings growth. Indeed, City analysts expect earnings per share to rattle comfortably higher over the medium term, and predict a 21% improvement in the current year alone.

Forecasters remain hugely optimistic over the insurer’s prospects despite a worrying return on equity (RoE) admission made in last week’s interims. RSA announced that it is expecting RoE to be below 10%, caused by poor weather conditions in Europe and Canada, news of which drove shares 6% lower on the day of the results.

Still, I believe that recent weakness presents a fresh buying opportunity for an exciting growth story. Indeed, the interims revealed that the company continues to generate tonnes of new business, and the firm saw net written premiums across the group rise 7% to £6.7bn during January-September.

While business rose 3% in its core UK and Western Europe markets, to £2.84bn, premiums in red-hot emerging markets surged 17% to £1.03bn, a promising omen for future growth. Indeed, RSA noted that Asia, the Middle East, as well as Central and Eastern Europe all performed well during the period. Elsewhere, net written premiums in major market Canada rose 14% to £1.34bn in January-September.

And following RSA’s predicted 21% earnings per share improvement this year, to 11.5p, the City’s number crunchers anticipate an additional 11% increase in 2014 to 12.8p. And these spectacular earnings projections provide the company with a price to earnings to growth (PEG) multiple of 0.5 and 0.8 for 2013 and 2014 respectively, well below the watermark of 1 that represents exceptional bang for your buck.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Royston does not own shares in RSA Insurance Group.

More on Investing Articles

Dividend Shares

A 12.65% yield? Here’s the dividend forecast for this FTSE income share

Jon Smith talks through the2026/27 dividend forecast for an income stock that already has a double-digit yield but could go…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Down 23% last year, here’s a FTSE 100 share that could rebound (and then some) in 2025!

Royston Wild thinks this dirt cheap FTSE 100 share has the ingredients to bounce back after a tough few years.…

Read more »

Investing Articles

2 beaten-down shares to consider for a Stocks and Shares ISA in 2025

These high-quality businesses have suffered recent share price setbacks. This writer thinks they're now worth considering for a Stocks and…

Read more »

Fans of Warren Buffett taking his photo
Investing For Beginners

This billionaire is copying Warren Buffett. Should I do the same?

Jon Smith reviews fresh news about how an investment billionaire is imitating Warren Buffett as he goes after an interesting…

Read more »

Investing Articles

I expect these 3 FTSE 100 shares to fly when inflation really starts to fall

Harvey Jones picks out three FTSE 100 shares whose fortunes should improve once inflation is finally on the run. They're…

Read more »

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »